Use of Device Therapies for Heart Failure How many tertiary-care patients with symptomatic HF due to systolic dysfunction are eligible for an ICD or a CRT-D on the basis of an established or emerging indications?
2005 Heart Failure Guidelines Previewed9/14/04 [Medscape Medical News] The new guidelines from the Heart Failure Society of America confirm that ACE inhibitors should be first-line therapy, but they also recommend being aggressive with beta-blockers; in addition, they comment on aldosterone antagonists, ICDs, and end-of-life care.
Legal Disclaimer
The materials presented here were prepared by independent authors under the editorial supervision of Medscape, and do not represent a publication of the Heart Failure Society of America. These materials and the related activity are not sanctioned by the Heart Failure Society of America or the commercial supporter of the conference, and do not constitute an official part of that conference.
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
